Treatment of Parkinson's Disease with Magnetic Fields Reduces the Requirement for Antiparkinsonian Medications

References

• Anton‐Tay F., Diaz J. L., Fernandez‐Guardiola A. On the effects of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Boyd A. E., Reichlin S., Turksoy N. Galactorrhoea‐amenorrhoea syndrome: diagnosis and therapy. Annals of Internal Medicine 1977; 87: 165–175
   PubMed Web of Science ®Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid‐brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Burton S., Daya S., Potgieter B. Melatonin modulates apomorphine‐induced rotational behaviour. Experientia 1991; 47: 466–469
   PubMedGoogle Scholar
• Cardinali D. P., Vacas M. I., Boyer E. E. Specific binding of melatonin in bovine brain. Endocrinology 1979; 105: 437–441
   PubMed Web of Science ®Google Scholar
• Cotzias C. G., Papavasiliou P. S., Gellene R. Modification of parkinsonism: chronic treatment with L‐dopa. New England Journal of Medicine 1969; 280: 337–345
   PubMed Web of Science ®Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movement induced by L‐dopa in mice. Science 1971; 173: 450–452
   PubMed Web of Science ®Google Scholar
• Cummings J. L. Depression and Parkinson's disease: a review. American Journal of Psychiatry 1992; 149: 443–454
   PubMed Web of Science ®Google Scholar
• Dubocovich M. L. Melatonin as a potent modulator of dopamine release in the retina. Nature 1983; 306: 782–784
   PubMed Web of Science ®Google Scholar
• Factor S. A., McAlarney T., Sanchez‐Ramos J. R., Weiner W. J. Sleep disorders and sleep effect in Parkinson's disease. Movement Disorders 1990; 5: 280–285
   PubMed Web of Science ®Google Scholar
• Fujiumra H., Umbach I. Role de l'atteinte de la substance reticulee dans la demence de la maladie de Parkinson. Revue Neurologique (Paris) 1987; 143: 108–114
   PubMed Web of Science ®Google Scholar
• Goodwin F. K., Murphy D. L., Brodie H. K. H., Bunney W. E. Levodopa: alterations in behaviour. Clinical Pharmacology and Therapeutics 1971; 12: 383–396
   PubMedGoogle Scholar
• Greenfield J. G., Bosanquet F. D. The brainstem lesions in Parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 1953; 16: 213–226
   PubMed Web of Science ®Google Scholar
• Heilman K. M. Neglect and related disorders. Clinical neuropsychology, K. M. Heilman, E. Valenstein. Oxford University Press, Oxford 1979; 268–307
   Google Scholar
• Heilman K. M., Schwartz H., Watson R. T. Hypoarousal in patients with neglect syndrome and emotional indifference. Neurology 1978; 28: 229–232
   PubMed Web of Science ®Google Scholar
• Heilman K. M., Watson R. T., Valenstein E. Neglect and related disorders. Clinical neuropsychology, K. M. Heilman, E. Valenstein. Oxford University Press, Oxford 1985; 243–293
   Google Scholar
• Henderson V. W., Wooten G. F. Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?. Neurology 1981; 3: 132–137
   Google Scholar
• Huber S. J., Paulson G. W., Shuttleworth E. C. Depression in Parkinson's disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1988; 1: 47–51
   Google Scholar
• Hughes R. C., Polgar J. G., Weightman D., Walton J. N. Levodopa in parkinsonism: the effects of withdrawal of anticholinergic drugs. British Medical Journal 1971; 2: 487–491
   PubMed Web of Science ®Google Scholar
• Kales A., Ansel R. D., Markham C. H., Scharf M. B., Tan T. L. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clinical Pharmacology and Therapeutics 1971; 12: 397–406
   PubMed Web of Science ®Google Scholar
• Koller W. C., Hubble J. P. Levodopa therapy in Parkinson's disease. Neurology 1990; 40(supp 3)40–47
   Google Scholar
• Koller W. C., Vetere‐Overfield B., Williamson A., Busenbark K., Nash J., Parrish D. Sexual dysfunction in Parkinson's disease. Clinical Neuropharmacology 1990; 13: 461–463
   PubMed Web of Science ®Google Scholar
• Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Kovacs G. L., Gayari I., Telegdy G., Lissak K. Effect of melatonin and pinealectomy on avoidance and exploratory activity in the rat. Physiology & Behavior 1974; 13: 349–355
   PubMed Web of Science ®Google Scholar
• Langston J. W., Forno L. S. The hypothalamus in Parkinson disease. Annals of Neurology 1978; 3: 129–133
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• Lees A. J., Blackburn N. A., Campbell V. L. The nighttime problems in Parkinson's disease. Clinical Neuropharmacology 1988; 11: 512–519
   PubMed Web of Science ®Google Scholar
• Lipe H., Longstreth W. T., Bird T. D., Linde M. Sexual function in married men with Parkinson's disease compared to married men with arthritis. Neurology 1990; 40: 1347–1349
   PubMed Web of Science ®Google Scholar
• Marsh G. G., Markham C. H. Does levodopa alter depression and psychopathology in parkinsonian patients?. Journal of Neurology, Neurosurgery and Psychiatry 1973; 36: 925–935
   PubMedGoogle Scholar
• Mayeux R. Mental state. Handbook of parkinson's disease, W. C. Koller. Marcel Dekker, New York 1987; 127–144
   Google Scholar
• Mayeux R., Stern Y., Rosen J., Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981; 31: 645–650
   PubMed Web of Science ®Google Scholar
• McCance‐Katz E. F., Marek K. L., Price L. H. Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology 1992; 42: 1813–1814
   PubMed Web of Science ®Google Scholar
• Mesulam M. M. A cortical network for directed attention and unilateral neglect. Annals of Neurology 1981; 10: 304–325
   Web of Science ®Google Scholar
• Nausieda P., Weiner W. J., Kaplan L. R., Weber S., Klwans H. L. Sleep disruption in the course of levodopa therapy: an early feature of the levodopa psychosis. Clinical Neuropharmacology 1982; 5: 183–194
   PubMed Web of Science ®Google Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. European Journal of Pharmacology 1979; 55: 219–220
   PubMed Web of Science ®Google Scholar
• Nutt J. G., Hammerstad J. P., Gancher S. T. Parkinson's disease. Edward Arnold, London 1992; 52–53
   Google Scholar
• Ogasahara S., Nishikawa Y., Takahashi M. Dopamine metabolism in the central nervous system after discontinuation of L‐dopa therapy in patients with Parkinson's disease. Journal of Neurological Sciences 1984; 66: 151–163
   PubMedGoogle Scholar
• Paulson G. W. Management of patients with Parkinson's disease who fail to respond to levodopa. Continuing EducationMay edition. 1986; 234–240
   Google Scholar
• Pazo J. H. Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin 1979; 4: 727–730
   Web of Science ®Google Scholar
• Pearce J. Mental changes in parkinsonism. British Medical Journal 1974; 2: 445
   PubMed Web of Science ®Google Scholar
• Raft D., Newman M., Spencer R. Suicide on L‐dopa. Southern Medical Journal 1972; 65: 312
   PubMedGoogle Scholar
• Rinne U. K., Sonninen V., Siirtola T., Marttila R. Long‐term responses of parkinson's disease to levodopa therapy. Journal of Neural Transmission 1980; 16: 149–156, (suppl)
   Google Scholar
• Rozencwaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Sallanon M., Claustrat B., Touret M. Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica 1982; 101: 161–165
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. The effects of external picoTesla range magnetic fields on the EEG in Parkinson's disease. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of pico Tesla magnetic fields in Parkinson's disease. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Fisher H. Increased incidence of neuroleptic‐induced movement disorders in pinealectomized rats. International Journal of Neuroscience 1989; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. The relationship of the reticular system to the primary pathoetiology of Parkinson's disease. International Journal of Neuroscience 1988; 42: 297–300
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Enhancement of visuoperceptive functions by pico Tesla range magnetic fields in patients with Parkinson's disease. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Iacono R. P. Reversal of micrographia in Parkinson's disease by application of pico Tesla range magnetic fields. International Journal of Neuroscience
   Google Scholar
• Sandyk R. Weak magnetic fields as a novel therapeutic modality in Parkinson's disease (Editorial). International Journal of Neuroscience 1992a; 66: 1–15
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields in the treatment of Parkinson's disease with the “on‐off” phenomenon. International Journal of Neuroscience 1992b; 66: 97–106
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of Parkinsonism. International Journal of Neuroscience 1992c; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R. Book review. Parkinson's disease. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Anninos P. A., Tsagas N., Derpapas K. Magnetic fields in the treatment of Parkinson's disease. International Journal of Neuroscience 1992; 63: 141–150
   PubMed Web of Science ®Google Scholar
• Sandyk R., lacono R. P., Bamford C. R. The hypothalamus in Parkinson's disease. Italian Journal of Neurological Sciences 1987; 8: 227–234
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P., Kay S. R. The hypothalamus in MPTP‐induced parkinsonism. Italian Journal of Neurological Sciences 1990; 11: 367–372
   PubMedGoogle Scholar
• Schiffer R. B., Kurlan R., Rubin A., Boer S. Evidence for atypical depression in Parkinson's disease. Evidence for atypical depression in Parkinson's disease. American Journal of Psychiatry 1988; 145: 1020–1022
   PubMed Web of Science ®Google Scholar
• Sechi G. P., Tanda F., Mutani R. Fatal hyperpyrexia after withdrawal of levodopa. Neurology 1984; 34: 249–251
   PubMed Web of Science ®Google Scholar
• Seguela P., Geffard M., Chauveau J., Muyard J. P., Biziere K., Le Moal M. Selective increase of melatonin content in pineal gland and nucleus accumbens after peripheral injection of Des‐Tyr1‐gamma‐endorphin in the rat. Neuroscience Letters 1982; 10: S442
   Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth‐strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore‐Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Singer C., Sanchez‐Ramos J., Weiner W. J., Ackerman M. Sexual dysfunction in parkinsonian men. Neurology 1989; 39(suppl 1)145
   Google Scholar
• Smythe G. A., Lazarus L. Growth hormone response to melatonin in man. Science 1974a; 184: 1373–1374
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. Journal of Clinical Investigations 1974b; 54: 116–121
   PubMed Web of Science ®Google Scholar
• Snider S. R., Sandyk R. Sensory dysfunction. Handbook of parkinson's disease, W. C. Roller. Marcel Dekker, Inc, New York 1987; 171–180
   Google Scholar
• Stein M. B., Heuser I. J., Juncos J. L., Uhde T. W. Anxiety disorders in patients with Parkinson's disease. American Journal of Psychiatry 1990; 147: 217–220
   PubMed Web of Science ®Google Scholar
• Tanner C. M., Goetz C. G., Klawans H. L. Autonomic nervous system dysfunction. Handbook of Parkinson's disease, W. C. Koller. Marcel Dekker, New York 1987; 145–170
   Google Scholar
• Timberlake W. H., Vance M. A. Four‐year treatment of patients with parkinsonism using amantadine alone or with levodopa. Annals of Neurology 1978; 3: 119–128
   PubMedGoogle Scholar
• Van der Linden C., Jankovic J., Jansson B. Lateral hypothalamic dysfunction in Parkinson's disease. Annals of Neurology 1985; 18: 137–138
   Web of Science ®Google Scholar
• Vitte P. A., Harthe C., Lestage P., Claustrat B., Bobillier P. Plasma, CSF and brain distribution of C14‐melatonin in rat: a biochemical and autoradiographic study. Journal of Pineal Research 1988; 5: 437–453
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N‐acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Anderson L. E., Hilton D. I., Phillips R. D. Chronic exposure to 60‐Hz electric fields: effects on pineal function in the rat. Bioelectromagnetics 1981; 2: 371–380
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60‐Hz electric field effects on pineal melatonin rhythms. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry. Brain research 1983; 272: 378–381
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Brain Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Circadian variations in the inhibition of dopamine release from adult and newborn rat hypothalamus by melatonin. Neuroendocrinology 1985; 40: 102–108
   PubMed Web of Science ®Google Scholar